FDA Expands October ANDA Numbers With First-Cycle Approval Totals

Drug Industry Daily
A A
The FDA fleshed out its public numbers on ANDA approvals for the first month of GDUFA II, notably underscoring 26 first-cycle approvals, plus two tentative.

To View This Article:

Login

Subscribe To Drug Industry Daily